Serum heparanase levels and left atrial/left atrial appendage thrombus in patients with nonvalvular atrial fibrillation
dc.authorid | 0000-0001-5207-5846 | en_US |
dc.authorid | 0000-0001-6595-7493 | en_US |
dc.authorid | 0000-0003-1784-3584 | en_US |
dc.authorid | 0000-0002-9653-9048 | en_US |
dc.authorid | 0000-0002-4601-3937 | en_US |
dc.contributor.author | Yılmaz, Mehmet Fatih | |
dc.contributor.author | Acar, Emrah | |
dc.contributor.author | İnanır, Mehmet | |
dc.contributor.author | Karabay, Can Yücel | |
dc.contributor.author | İzgi, İbrahim Akın | |
dc.date.accessioned | 2023-07-17T12:07:12Z | |
dc.date.available | 2023-07-17T12:07:12Z | |
dc.date.issued | 2022 | en_US |
dc.department | BAİBÜ, Tıp Fakültesi, Dahili Tıp Bilimleri Bölümü | en_US |
dc.description.abstract | Introduction Data regarding the possible role of heparanase (HPA) in the occurrence of left atrial/left atrial appendage (LA/LAA) thrombus in patients with atrial fibrillation (AF) is lacking. The goal of the present study was to assess the association between plasma levels of HPA and LA/LAA thrombus in AF. Methods A total of 687 patients with nonvalvular AF (NVAF) without anticoagulation therapy were included from January 2016 to June 2019. Serum HPA analysis was performed with a commercially available human ELISA kit. Logistic regression models were used to test for association. Results Serum HPA levels were significantly higher in patients with LA/LAA thrombus than in those without LA/LAA thrombus (270.8 [193.4 +/- 353.2] pg/mL vs 150.3 [125.2 +/- 208.4] pg/mL; P < 0.001). In multivariate analysis, serum HPA remained a significantly independent predictor of LA/LAA thrombus (odds ratio 1.674, 95% confidence interval [CI] 1.339-2.289, P < 0.001). In the receiver operating characteristic (ROC) curve analysis, HPA showed a predictive value with an area under the curve (AUC) of 0.757 (95% CI 0.652-0.810, P < 0.001). The optimal cutoff level for HPA predicting LA/LAA thrombus was 210.7 pg/mL, with a sensitivity of 74.3% and a specificity of 64.8%. Conclusion An elevated HPA level was associated with the presence of LA/LAA thrombus in patients with AF. HPA might portend the risk for the prothrombotic state in AF patients. | en_US |
dc.identifier.citation | Yilmaz, M. F., Acar, E., Inanir, M., Karabay, C. Y., & Izgi, I. A. (2022). Serum heparanase levels and left atrial/left atrial appendage thrombus in patients with nonvalvular atrial fibrillation. Herz, 47(3), 251-257. | en_US |
dc.identifier.doi | 10.1007/s00059-021-05052-z | |
dc.identifier.endpage | 257 | en_US |
dc.identifier.issn | 0340-9937 | |
dc.identifier.issn | 1615-6692 | |
dc.identifier.issue | 3 | en_US |
dc.identifier.pmid | 34351431 | en_US |
dc.identifier.scopus | 2-s2.0-85111870642 | en_US |
dc.identifier.scopusquality | Q3 | en_US |
dc.identifier.startpage | 251 | en_US |
dc.identifier.uri | http://dx.doi.org/10.1007/s00059-021-05052-z | |
dc.identifier.uri | https://hdl.handle.net/20.500.12491/11300 | |
dc.identifier.volume | 47 | en_US |
dc.identifier.wos | WOS:000681564300001 | en_US |
dc.identifier.wosquality | Q4 | en_US |
dc.indekslendigikaynak | Web of Science | en_US |
dc.indekslendigikaynak | Scopus | en_US |
dc.indekslendigikaynak | PubMed | en_US |
dc.institutionauthor | İnanır, Mehmet | |
dc.language.iso | en | en_US |
dc.publisher | URBAN & VOGEL | en_US |
dc.relation.ispartof | Herz | en_US |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | en_US |
dc.rights | info:eu-repo/semantics/closedAccess | en_US |
dc.subject | Heparanase | en_US |
dc.subject | Left Atrium | en_US |
dc.subject | Procoagulant | en_US |
dc.subject | Thrombus | en_US |
dc.subject | Echokardiografie | en_US |
dc.subject | Procoagulant Activity | en_US |
dc.title | Serum heparanase levels and left atrial/left atrial appendage thrombus in patients with nonvalvular atrial fibrillation | en_US |
dc.type | Article | en_US |